On April 30, 2025, TriSalus Life Sciences, Inc. announced a $22 million private placement of 5.5 million shares at $4.00 each, alongside planned measures for the exchange of preferred stock and projected revenues of approximately $9.2 million for Q1 2025, marking a 42% increase from the previous year.